"This study suggests that the ARC-HBR and PRECISE-DAPT bleeding criteria can be used to risk stratify patients and guide the therapeutic selection to lower the bleeding risk. For instance, we found ...

PHILADELPHIA — Gastrointestinal (GI) bleeding after percutaneous coronary intervention (PCI) among patients on dual antiplatelet therapy (DAPT) remains risky in terms of morbidity and mortality, but ...

A newly developed tool—called the PRECISE-DAPT score—enables the identification of patients who have a high risk of out-of-hospital bleeding in the year after PCI, potentially easing individualized ...

Please provide your email address to receive an email when new articles are posted on . Among patients at high ischemic and bleeding risk, longer duration of dual antiplatelet therapy after PCI for ...

Long-term dual antiplatelet therapy (DAPT) reduces ischemic events without a trade-off in bleeding compared with shorter durations among ACS patients who undergo PCI, according to new registry data ...

The investigators of PRECISE-DAPT devised a five-item score to predict out-of-hospital bleeding risk in patients treated with dual antiplatelet therapy (DAPT) after coronary stenting. In patients at ...

BERN, SWITZERLAND — The newly developed PRECISE-DAPT score could help clinicians predict the risk of out-of-hospital bleeding after PCI and guide in selecting the duration of dual antiplatelet therapy ...